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Abstract: Aspergillus fumigatus is a ubiquitous saprophytic mold and a major pathogen in
immunocompromised patients. The effectiveness of triazole compounds, the A. fumigatus first line
treatment, is being threatened by a rapid and global emergence of azole resistance. Whole genome
sequencing (WGS) has emerged as an invaluable tool for the analysis of genetic differences between
A. fumigatus strains, their genetic background, and antifungal resistance development. Although WGS
analyses can provide a valuable amount of novel information, there are some limitations that should
be considered. These analyses, based on genome-wide comparative data and single nucleotide
variant (SNV) calling, are dependent on the quality of sequencing, assembling, the variant calling
criteria, as well as on the suitable selection of the reference genome, which must be genetically close to
the genomes included in the analysis. In this study, 28 A. fumigatus genomes sequenced in-house and
73 available in public data bases have been analyzed. All genomes were distributed in four clusters
and showed a variable number of SNVs depending on the genome used as reference (Af293 or A1163).
Each reference genome belonged to a different cluster. The results highlighted the importance of
choosing the most suitable A. fumigatus reference genome to avoid misleading conclusions.
Keywords: Aspergillus fumigatus; whole genome sequencing; reference genomes; azole resistance; cyp51A
1. Introduction
Aspergillus fumigatus is a saprophytic filamentous fungus and the principal causative agent of
human aspergillosis [1,2]. There are many types of diseases caused by A. fumigatus and their symptoms
vary according to the site of infection and host health condition. Predominantly, this species causes
invasive infections, such as invasive pulmonary aspergillosis (IPA), with high mortality rates in
immunocompromised or immunosuppressed patients [3–5]. Currently, the treatment options are
limited to three classes of antifungal drugs (azoles, echinocandins and polyenes) and azoles are drugs
of first line for treating Aspergillus-caused diseases. However, azole drug efficacy is threatened by the
worldwide spreading of resistance [6].
Despite all the technological improvements developed in recent years, many basic aspects about
the biology of this opportunistic pathogen remained largely unknown. Genomics and whole genome
sequencing (WGS) have emerged as useful tools to greatly enhance knowledge and understanding of
infectious diseases and clinical microbiology [7–10]. In this context, genome-wide sequencing using
high throughput sequencing (HTS) together with alignment comparison analysis has been described as
Genes 2018, 9, 363; doi:10.3390/genes9070363 www.mdpi.com/journal/genes
Genes 2018, 9, 363 2 of 19
a good approach to identify single nucleotide variants (SNVs) or polymorphisms (SNPs) for the analysis
of genetic differences between A. fumigatus strains [11]. The genetic diversity between isolates can be
used to explain many different aspects such as the strain background lineage, strain specific virulence
phenotypes, the potential factors involved in antifungal resistant development, and more commonly,
determining the genetic strain relatedness in epidemiological surveillance and outbreak studies [12–14].
Although WGS studies provide a valuable amount of novel data, there are some considerations
that should be taken into account. To date, most WGS analyses are based on identifying SNVs in a set of
strains in comparison to a reference genome, and consequently the results will be completely dependent
on the chosen reference. Therefore, the identified SNVs will have a different significance depending
on how genetically close the reference genome will be from the strains included in the analysis.
Classically, most advances have been focused on unravelling the genomics of two different A. fumigatus
reference strains [15], Af293 (AAHF00000000.1) and A1163 (ABDB00000000.1), or their derivatives.
First, the Af293 strain was fully sequenced in 2005 [16], and soon after, the A1163 strain was the second
A. fumigatus genome sequenced by the J. Craig Venter Institute [17]. This strain was a derivative of
another clinical isolate, the CBS144-89/CEA10. The first genome comparison between both strains
showed that despite high synteny and identity in most of the regions of their genomes, there were
some hundreds of genes unique from each strain and not present in the other [18]. This heterogeneity
could potentially lead to confusion, so care must be taken in drawing conclusions on different aspects
from a single genetic background [15]. A recent study carried out in our laboratory [19] showed
that the Af293 reference genome belonged to a specific lineage of A. fumigatus strains which harbors
five polymorphisms (F46Y, M172V, N248T, D255E, E427K) in cyp51A gene which codes for the azole
target. Based on these phylogenetic studies from whole genome sequencing, the other classic reference
genome, the A1163 strain, belonged to a different and distant phylogenetic lineage, which implies
that both genomes are significantly different. Also, and apart from the relevance of choosing the most
suitable reference genome, the quality of sequencing and assembling will be of great importance for
getting reliable results.
In this work, we describe the in-house genome sequencing and comparative analysis of 28
A. fumigatus genomes, including the A. fumigatus genomes of six strains routinely used in Aspergillus
basic research laboratories. All these genomes were distributed in four separate clusters, corresponding
to very different lineages. In addition, 73 A. fumigatus genomes, including azole susceptible and
resistant strains from a worldwide distribution, were included in the study. The whole sequence
analysis of these 101 A. fumigatus genomes provided information that led to an increase in the
knowledge of A. fumigatus genetic background and the development of azole resistance.
2. Materials and Methods
2.1. Aspergillus fumigatus Isolates
A total of 169 genomes were evaluated including in-house sequenced Aspergillus fumigatus isolates
and genomes downloaded from NCBI Sequence Read Archive (SRA) public database (www.ncbi.
nlm.nih.gov/sra). The genomic samples were selected following this criteria: (i) all genomes had to
be sequenced with Illumina platform; and (ii) had to be paired-end. After quality control filtering
(>85% mapping rate against Af293 reference genome and >95% of genome coverage at more than
10× depth of coverage), a total of 101 A. fumigatus strain genome sequences representing 8 different
geographical locations were selected for further analysis. Among them, 28 A. fumigatus strains were
from the Mycology Reference Laboratory Collection (Table 1). Most of them were clinical azole
susceptible strains. Some of them had specific cyp51A modifications: 12 strains harbored three changes
(F46Y, M172V, and E427K) and 3 strains had five (F46Y, M172V, N248T, D255E and E427K) [19].
Af293 was included in the latter group of five cyp51A modifications and sequenced again in-house
(named as AF293). Another group of A. fumigatus azole susceptible strains were isolates that have
been classically used as reference or control strains in most Aspergillus laboratories. This set of strains
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included the A1163 (also known as CEA10, CBS144.89, FGSC A1163 or AF10), AF237 (called CM237),
ATCC204305, akuBKU80 (FGSC A1160) [20], and ATCC46645. Two azole resistant strains without
modifications in cyp51A were also included and sequenced in this work (CM7510 and CM7555).
Table 1. Aspergillus fumigatus strains whole genome sequenced in our laboratory. The assigned lineage
was based on the phylogenetic study.
Samples Origin cyp51A Modifications AZL SC Mating Type Source Lineage
AF293 SP 5SNPs S M1.2 CL 3
akuBKU80 SP WT S M1.1 CL 1.1
ATCC204305 SP I242V S M1.1 CL 1.2
ATCC46645 SP WT S M1.1 CL 2.1
CEA10 SP WT S M1.1 CL 1.1
CM2141 SP WT S M1.1 CL 2.2
CM237 SP WT S M1.1 CL 1.1
CM2495 SP 3SNPs S M1.1 CL 4
CM2730 SP 3SNPs S M1.2 CL 4
CM2733 SP 3SNPs S M1.1 CL 4
CM3248 SP N248K S M1.1 CL 1.1
CM3249 SP 3SNPs S M1.1 CL 4
CM3249b SP 3SNPs S M1.1 CL 4
CM3262 SP 3SNPs S M1.1 CL 4
CM3720 SP 3SNPs S M1.1 CL 4
CM4602 SP 3SNPs S M1.2 CL 4
CM4946 SP 3SNPs S M1.2 CL 4
CM5419 SP WT S M1.2 CL 2.2
CM5757 SP WT S M1.2 CL 1.1
CM6126 SP WT S M1.2 CL 1.1
CM6458 SP WT S M1.2 CL 1.3
CM7510 SP WT R M1.1 CL 1.1
CM7555 SP WT R M1.2 CL 1.3
CM7560 SP 3SNPs S M1.1 CL 4
CM7570 SP 3SNPs S M1.1 CL 4
CM7632 SP 5SNPs S M1.1 CL 3
TP12 SP 5SNPs S M1.2 CL 3
TP32 SP 3SNPs S M1.1 CL 4
SP (Spain), SNPS (single nucleotide polymorphisms), 3SNPs cyp51A modifications (F46Y, M172V, E427K) and 5SNPs
cyp51A modifications (F46Y, M172V, N248T, D255E, E427K), AZL susceptibility (azole susceptibility), S (susceptible),
R (resistant), CL (clinical).
The remaining 73 strain genomes were obtained from public data bases and belonged
to strains from the United Kingdom, the Netherlands, Portugal, Denmark, India, Japan and
Canada [13,21,22] (NCBI SRA public database) (Table 2). Some of the isolates from The Netherlands
and India came from clinical samples (n = 8) and others from environmental soil sources (n = 8). Strains
from Japan, UK and Canada were all from clinical origin while the Portuguese strains had an unknown
origin (Table 2).
Table 2. Aspergillus fumigatus genomes from public data bases included in this study. The assigned
lineage is based on the phylogenetic study.
Samples Origin cyp51A Modifications AZL SC Mating Type Source Lineage Ref.
08-12-12-13 NT TR34/L98H, S297T, F495I R M1.1 CL 2.2 [13]
08-19-02-10 NT TR34/L98H R M1.2 ENV 2.2 [13]
08-19-02-30 NT WT S M1.1 ENV 1.3 [13]
08-19-02-46 NT TR34/L98H R M1.1 ENV 2.2 [13]
08-19-02-61 NT TR34/L98H R M1.1 ENV 2.2 [13]
08-31-08-91 NT TR34/L98H R M1.1 CL 2.2 [13]
08-36-03-25 NT TR34/L98H, S297T, F495I R Unclear CL 2.2 [13]
09-7500806 UK WT S M1.2 CL 1.3 [13]
10-01-02-27 NT TR34/L98H R M1.2 CL 2.2 [13]
12-7504462 UK WT S M1.2 CL 1.3 [13]
12-7504652 UK WT S M1.1 CL 2.1 [13]
12-7505054 UK WT S M1.1 CL 2.1 [13]
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Table 2. Cont.
Samples Origin cyp51A Modifications AZL SC Mating Type Source Lineage Ref.
12-7505220 UK TR34/L98H R M1.1 CL 2.2 [13]
12-7505446 UK TR34/L98H R M1.2 CL 2.2 [13]
Af293 UK 5SNPs S M1.2 CL 3 [13]
AF41 UK WT S M1.2 CL 1.1 [13]
Af65 UK WT S M1.2 CL 2.1 [13]
AF72 UK G54E R M1.2 CL 1.1 [13]
AF90 UK M220V R M1.1 CL 1.1 [13]
Afu1042-09 IN TR34/L98H R M1.1 CL 2.2 [13]
Afu124-E11 IN TR34/L98H R M1.1 ENV 2.2 [13]
Afu166-E11 IN TR34/L98H R M1.1 ENV 2.2 [13]
Afu218-E11 IN TR34/L98H R M1.1 ENV 2.2 [13]
Afu257-E11 IN TR34/L98H R M1.1 ENV 2.2 [13]
Afu343-P-11 IN TR34/L98H R Unclear CL 2.2 [13]
Afu591-12 IN TR34/L98H R M1.1 CL 2.2 [13]
Afu942-09 IN TR34/L98H R M1.1 CL 2.2 [13]
F12041 UK G138C R M1.2 CL 2.1 [21] *
F12219 UK G54R R M1.2 CL 1.1 [21] *
F12636 UK G54E R M1.1 CL 2.1 [21] *
F13535 UK G138C R M1.2 CL 2.1 [21] *
F13619 UK H147Y, G448S R M1.1 CL 2.1 [21] *
F13952 UK G138C R M1.2 CL 2.1 [21] *
F14403 UK G54R R M1.1 CL 1.1 [21] *
F14513G UK G138C R M1.2 CL 2.1 [21] *
F14532 UK M220T R M1.1 CL 2.1 [21] *
F14946G UK WT S M1.2 CL 1.1 [21] *
F15390 UK M220T R M1.1 CL 2.1 [21] *
F15927 CN 3SNPs S M1.1 CL 4 [21] *
F16134 DN M220K R M1.2 CL 1.1 [21] *
F16216 UK TR34/L98H R M1.2 CL 2.1 [21] *
F16311 UK WT S M1.1 CL 1.1 [21] *
F17582 UK WT S M1.2 CL 2.1 [21] *
F17729 UK WT S M1.2 CL 1.1 [21] *
F17729W UK WT S M1.2 CL 1.1 [21] *
F17764 CN WT S M1.1 CL 1.1 [21] *
F18085 UK WT S M1.1 CL 1.1 [21] *
F5211G UK WT S M1.1 CL 2.1 [21] *
F7763 UK 5SNPs S M1.1 CL 3 [21] *
IFM55369 JP WT S M1.1 CL 1.2 [22]
IFM58026 JP N248K S M1.2 CL 1.1 [22]
IFM58029 JP WT S M1.2 CL 1.2 [22]
IFM58401 JP WT S M1.2 CL 1.1 [22]
IFM59056 JP WT S M1.1 CL 1.1 [22]
IFM59073 JP WT S M1.2 CL 1.2 [22]
IFM59359 JP WT S Unclear CL 1.2 [22]
IFM59361 JP WT S M1.1 CL 1.3 [22]
IFM59365 JP WT S M1.2 CL 1.1 [22]
IFM59777 JP WT S M1.1 CL 1.2 [22]
IFM60514 JP WT S M1.2 CL 1.1 [22]
IFM61118 JP N248K S M1.1 CL 1.1 [22]
IFM61407 JP WT S Unclear CL 1.1 [22]
IFM61578 JP P216L S M1.2 CL 1.1 [22]
IFM61610 JP WT S M1.2 CL 1.1 [22]
IFM62516 JP P329P S M1.1 CL 1.2 [22]
SL143435 PT N248K S M1.2 UNK 1.1 *
SL143436 PT WT S M1.2 UNK 1.1 *
SL143437 PT WT S M1.1 UNK 1.3 *
SL143438 PT N248K S M1.2 UNK 1.1 *
SL143439 PT WT S M1.1 UNK 1.3 *
SL143440 PT 3SNPs S M1.1 UNK 4 *
SL143441 PT WT S M1.1 UNK 1.1 *
SL146112 PT N248K S M1.2 UNK 1.1 *
NT (the Netherlands), UK (the United Kingdom), IN (India), CN (Canada), JP (Japan), PT (Portugal). SNPs (single
nucleotide polymorphisms), 3SNPs cyp51A modifications (F46Y, M172V, E427K) and 5SNPs cyp51A modifications
(F46Y, M172V, N248T, D255E, E427K), AZL SC (azole susceptibility), S (susceptible), R (resistant), CL (clinical),
ENV (environmental), UNK (unknown), * NCBI SRA.
2.2. DNA Extraction and Aspergillus fumigatus Identification
First, conidia from each selected strain were cultured in 3 mL of glucose-yeast extract-peptone
(GYEP) broth (2% glucose, 0.3% yeast extract, 1% peptone; OXOID LTD, Basingstoke, Hampshire,
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England) and grown overnight at 37 ◦C, after which mycelium mats were harvested and DNA was
extracted [23]. The A. fumigatus Spanish isolates included in this work were identified to the species
level on the basis of PCR amplification and sequencing of the internal transcribed spacer (ITS) region
and the partial amplification of the β-tubulin gene [24].
2.3. DNA Quality and Quantity Assessment
The DNA quality and quantity was assessed using a spectrophotometer (Thermo Scientific
NanoDrop One Spectrophotometer, Waltham, MA, USA). Since genomic DNA (gDNA) must be clean
and pure for preparing WGS libraries, when the 260/280 or 260/230 rates were lower than 1.8 or
higher than 2.2, the DNA was rejected. The strain was extracted again from a new mycelium mat and
its quality was assessed. Genomic DNA (gDNAs) were stored at −20 ◦C until further use.
2.4. Screening of cyp51A Changes: PCR Amplification and Sequence Analysis
The full coding sequences of cyp51A including its promoter, were amplified and sequenced using
the PCR conditions described before [25]. To exclude the possibility that any change identified in the
sequences was due to PCR-induced errors, each isolate was independently analyzed twice. Isolates
were screened for the presence of tandem repeat insertions in the cyp51A promoter region, as well as
for the presence of other cyp51A modifications. All the nucleotide sequences were analyzed using the
DNASTAR Lasergene package (DNASTAR Inc., Madison, WI, USA).
2.5. DNA Library Preparation and Illumina Whole-Genome Sequencing
Genomic DNA was extracted as previously described. Genomic DNA were quantified afterwards
using the QuantiFluor ® dsDNA System and the QuantiFluor ® ST Fluorometer (Promega, Madison,
WI, USA) and their quality was determined with the Agilent 2100 Bioanalyzer (Agilent Technologies,
Inc., Santa Clara, CA, USA). The preparation of fragmented gDNA libraries was performed using
Nextera ® XT Library Prep Kit (Illumina Inc., San Diego, CA, USA), according to the manufacturer’s
protocols. The mean fragment length of the libraries ranged from 800 to 1800 bp. Sequencing was
conducted in paired-end 2 × 150 bp on a NextSeq 500 system, according to the manufacturer’s
protocols (Illumina Inc., San Diego, CA, USA).
2.6. Whole-Genome Sequencing Alignment
The Illumina reads were trimmed using Trimmomatic (version 0.32) [26]. The sequencing adapters
and sequences with low quality scores on 3′ ends (Phred score [Q], <20) were trimmed. Raw Illumina
WGS reads were quality checked performing a quality control with FastQC (version 0.11.3;
Babraham Institute). Data sets were analyzed against two different A. fumigatus reference genomes,
the Af293 (GenBank accession number AAHF00000000.1) and the A1163 (GenBank accession
number ABDB00000000.1) using WGS-outbreaker v1.0 (Instituto de Salud Carlos III, Madrid, Spain)
(https://github.com/BU-ISCIII/WGS-Outbreaker) with default parameters. The pipeline comprised
all steps needed for SNV analysis using whole genome sequencing data. Mapping against genome
reference was performed with bwa mem (version 0.7.12-r1039) [27], duplicated reads removed using
Picard (version 1.140) (http://broadinstitute.github.io/picard), and the bedtools coverage v2.26
program [28] was used to perform further quality controls. Hereafter, in order to identify genetic
variations among strains, single nucleotide variant (SNV) detection (variant calling) and SNV matrix
generation were performed using GATK version 3.8.0 [29] with best practices parameters. ENSEMBL
variant effect predictor script (version 88) was used for variant annotation. The whole genome
sequencing project has been deposited in NCBI SRA (project accession number SRP151231).
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2.7. Phylogenetic Analysis and Single Nucleotide Variant Comparison
Final step of WGS-Outbreaker pipeline comprised Maximum-likelihood trees construction using
RaxML software (version 8.2.9) [30] with GTRCAT model and 100 bootstrap replicates. Phylogenetic
trees were visualized and annotated using ggtree R package [31]. SNV comparisons were performed
using a custom R script, mapping all genomes to Af293 and A1163 reference genomes.
2.8. Analysis of Genetic Diversity
Genetic diversity was calculated using the Molecular Evolutionary Genetics Analysis software
(MEGA, version 7) [32]. The A. fumigatus population was analyzed according to the formed groups
(clusters and subclusters) from the previous phylogenic studies. In MEGA, evolutionary distances
between sequences can be estimated by computing the number or proportion of nucleotide differences
between sequences using the FASTA alignment against each reference genome [33]. Two different
models have been used in this work, the p-distance model and another based on the number of
differences; (i) the p-distance model calculates the distance as the proportion of different nucleotide
sites compared. It is obtained by dividing the number of nucleotide differences (transitions and
transversions) by the total number of nucleotides compared. As recommended [34], when the genetic
distance was estimated, the complete-deletion option was used, since it normalizes the number of
differences based on the number of valid sites compared, not taking into account the alignment gaps
and missing data that sequences could contain. However, this model does not make any correction
for multiple substitutions at the same site, substitution rate biases (for example, differences in the
transitional and transversional rates), or differences in evolutionary rates among sites; (ii) The second
model, based on the number of differences, estimates the genetic distances according to the number
of sites at which the compared sequences differ (transitions and transversions). In this model,
the complete-deletion option was also used.
2.9. Determining Modifications in Genes of Interest
In order to see if the population structure could be based on particular genomic modifications,
some genes that have already been described as important in A. fumigatus biology were analyzed
in depth in each of the A. fumigatus population clusters formed from the SNV comparisons. One of
the genes was the cyp51A gene including its promoter (AFUA_4G06890 in Af293, and AFUB_063960
in A1163). This region was used to determine the azole resistant phenotype based on the resistance
mechanism. Since both reference genomes, Af293 and A1163, have opposite mating types, the mating
locus genes were included in the analysis: Mat1.1.1 (AFUB_042900), Mat1.2.1 (AFUA_3G06170),
and Mat1.2.4 (AFUA_3G06160). The presence or absence of these loci was also tested in all genomes
using srst2 software (version 0.1.8) [35]. Every gene of interest was analyzed independently in
all genomes.
2.10. Visualization of Depth of Coverage
An exploratory approach using Circos (v 0.69.3) [36], a tool to represent visual data, was used
to plot the depth of coverage of 20 whole-sequenced genomes selected to represent each cluster and
subcluster in comparison to the Af293 reference genome. Mean coverage data in 10,000 length bins was
calculated from bam files with bedtools (version 2.2.17) (http://bedtools.readthedocs.io/en/latest/).
2.11. Mating Type Analysis
A mapping approach was used in order to identify genes associated with each mating type.
Since Af293 was Mat1.2 and A1163 was Mat1.1, all samples were mapped against both references
using the workflow displayed in Figure S1: (i) samples that had been determined with srst2 as
Mat1.2 and mapped against A1163 were selected, and unmapped reads were retained in this step;
(ii) the unmapped reads were then mapped against Af293. Statistics of coverage and depth of coverage
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were calculated for all genes annotated in A1163 reference genome using the bam generated in this
step; (iii) genes with at least 70% of coverage were selected; (iv) to discard genes that may be found
due to the lack of presence in the A1163 assembly, the same procedure was performed for Mat1.1
samples; (v) finally, genes in common among all Mat1.2 samples minus one but not present in any
Mat1.1 sample were exported as a result (Figure S1A). The reverse procedure was performed starting
with Mat1.1 samples determining the genes only present in Mat1.1 samples (Figure S1B).
3. Results
3.1. Species Identification
The isolates were identified at the species level and also the azole resistance mechanism was
analyzed by PCR amplification and sequencing of the cyp51A gene and its promoter as explained in
Materials and Methods section. All the strains were identified as A. fumigatus sensu stricto. The azole
susceptibility profile of most of the strains sequenced in the laboratory is described elsewhere [19].
For the remaining strains, the azole susceptibility profile was determined based on the known
cyp51A modifications detected by WGS analysis. According to the azole resistance mechanism,
the A. fumigatus strains included in this study harbored the following cyp51A modifications: (i) strains
with cyp51A single point mutations (G54E/R, M220V/T/K, and G138C) or double point mutations
(G448S together with H147Y) in the minority of cases (only one strain); or (ii) strains with tandem
integrations and cyp51A modifications (TR34/L98H, TR34/L98H/S297T/F495I). Two azole resistant
cyp51A wild type (WT) strains were also included. All these strain features (cyp51A modifications and
azole susceptibility profile, as well as the geographical origin and mating type), were described in
Tables 1 and 2. Afterwards, the DNAs were further analyzed using WGS.
3.2. Whole-Genome Sequencing Analysis
All genome sequences mapped to a range of 85–99% genome coverage with at least 10x of depth
of coverage and a mapping rate > 94% against Af293 reference genome. Similarly, sequences were
mapped to a range of 84–99% genome coverage with at least 10× of depth of coverage against A1163
reference with a mapping rate > 88% (Table S1). The Af293 and the A1163 strains were resequenced
in our laboratory (and named hereafter AF293 and CEA10) and had a total of 313 and 1009 SNVs,
respectively, compared to their respective reference genomes.
3.3. Phylogenetic Analysis
Phylogenetic analysis using SNV data of Spanish genomes (Table 1) clearly showed that our strains
were divided into four clusters independently of the genome used as reference (Figure 1, with Af293 as
reference genome and Figure 2, with A1163 as reference genome). In this previous analysis, the different
wild type reference strains used, akuBKU80 and CEA10 as derivative strains of A1163, AF293, CM237,
ATCC204305 and ATCC46645 were located in separated clusters (Figures 1 and 2). Those clusters
were further confirmed when the remaining 73 A. fumigatus genomes available from other countries
were included.
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Figure 1. Whole genome phylogenetic analysis of 101 Aspergillus fumigatus genomes included in the
study. Dendrogram was performed using Af293 as reference genome.
Therefore, based on phylogenetic analysis, the complete A. fumigatus population was divided
into four well defined clusters (I, II, III, and IV). Two of them could be further subdivided into
subclusters: cluster I split in 3 subclusters (I.1, I.2, I.3), and cluster II in 2 (II.1, II.2). Clusters III and IV
remained undivided, because any subcluster was identified. Each subcluster was considered as an
independent population group, and was used to compare itself against each reference genome (Table 3).
The two reference genomes used were distributed in different clusters when compared against the
other: A1163 in cluster I and Af293 in cluster III. The number of clusters and the tree topology was
maintained regardless of the reference genome chosen.
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Figure 2. Whole genome phylogenetic analysis of 101 Aspergillus fumigatus genomes included in the
study. Dendrogram was performed using A1163 as reference genome.
Table 3. Mean of single nucleotide variants (SNVs). Variants within clusters and subclusters compared
to both reference genomes.
Phylogenetic Groups SNVs vs. A1163 Reference Genome SNVs vs. Af293 Reference Genome
Subcluster I.1 34,544 75,653
Subcluster I.2 40,124 65,121
Subcluster I.3 46,811 79,899
Subcluster II.1 81,478 98,423
Subcluster II.2 80,994 97,749
Cluster III 82,235 35,268
Cluster IV 158,154 159,742
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Based on cyp51A modifications, azole susceptible cyp51A-WT strains together with azole resistant
cyp51A single point mutation strains were grouped together in cluster I. In cluster II, there were azole
susceptible and resistant strains, with both cyp51A single point mutations and TR34/L98H mechanisms.
In cluster III, a set of strains with five cyp51A modifications (F46Y, M172V, N248T, D255E, E427K)
grouped together. While in cluster IV strains with three cyp51A modifications (F46Y, M172V, E427K)
also grouped together [19]. The Netherlands, Portugal and Canada genomes were distributed in
two clusters. The United Kingdom genomes were distributed in three, while Japanese genomes
(cyp51A-WT) were only in cluster I and Indian genomes (cyp51A-TR34) in cluster II. Except for the
tightly clustered isolates from India in cluster II.2, there was no relationship between the geographical
origin of the isolates and the cluster where they grouped.
3.4. Single Nucleotide Variant Analysis against Both References
To explore the genomic differences between the clusters formed from phylogenetic studies,
total SNVs between populations were determined. There were a total of 93,609 and 71,844 SNV
positions identified against the reference genomes, Af293 and A1163, respectively. No noticeable
differences were found in the SNV ranges when all strains were mapped against Af293 (313–165,788)
or A1163 (1043–163,367). However, the number of specific SNVs identified in each strain was notably
different depending on the genome that was used as reference (Table 4). In fact, some particular
SNVs previously detected in our laboratory by PCR (L98H, F46Y, M172V, N248T, D255E, E427K)
were specifically searched for in both reference whole genomes. The L98H variant was found in
all genomes that harbored this mutation since none of the reference genomes had this change in
its own genome. However, the remaining 5 SNVs (F46Y, M172V, N248T, D255E, E427K) were only
detected when the reference genome chosen was the A1163 genome, as Af293 specifically harbored
these 5 same polymorphisms.
Table 4. Single nucleotide variant differences compared to both reference genomes. Variants of each
A. fumigatus genome included in this study.
Samples A1163 Af293 Samples A1163 Af293 Samples A1163 Af293
08-12-12-13 80,791 91,956 CM2495 151,089 148,524 F17582 79,598 97,024
08-19-02-10 75,401 89,762 CM2730 157,505 159,177 F17729 44,054 79,106
08-19-02-30 42,487 87,831 CM2733 154,361 160,494 F17729W 43,663 78,416
08-19-02-46 78,449 96,243 CM3248 22,834 74,568 F17764 25,812 70,013
08-19-02-61 80,244 96,416 CM3249 157,242 159,900 F18085 51,241 78,553
08-31-08-91 88,972 98,911 CM3249b 154,510 157,780 F5211G 82,091 99,726
08-36-03-25 83,921 102,006 CM3262 161,695 160,926 F7763 84,764 55,332
09-7500806 45,286 74,134 CM3720 156,600 158,781 IFM55369 42,849 64,003
10-01-02-27 72,487 93,299 CM4602 155,381 161,767 IFM58026 22,186 68,777
12-7504462 48,927 75,301 CM4946 158,692 161,082 IFM58029 36,521 63,106
12-7504652 80,203 93,323 CM5419 89,354 99,771 IFM58401 26,669 63,489
12-7505054 86,952 101,471 CM5757 36,027 74,420 IFM59056 30,841 61,481
12-7505220 75,479 100,229 CM6126 55,871 86,902 IFM59073 43,230 68,775
12-7505446 86,194 100,736 CM6458 42,482 71,670 IFM59359 39,309 67,118
Af293 83,486 313 CM7510 33,559 79,283 IFM59361 42,795 73,228
AF293 78,045 659 CM7555 51,657 77,679 IFM59365 21,830 74,248
AF41 34,879 72,914 CM7560 158,657 153,769 IFM59777 40,117 65,300
Af65 90,143 103,614 CM7570 160,908 162,292 IFM60514 39,629 75,765
AF72 35,271 73,632 CM7632 81,519 25,490 IFM61118 21,905 70,230
AF90 40,262 73,395 F12041 78,812 93,712 IFM61407 32,025 76,034
Afu1042-09 80,346 96,348 F12219 35,440 73,872 IFM61578 26,201 67,946
Afu124-E11 81,115 97,509 F12636 80,359 98,501 IFM61610 41,690 74,102
Afu166-E11 80,948 97,350 F13535 78,741 93,777 IFM62516 41,229 67,364
Afu218-E11 80,571 96,955 F13619 85,412 107,985 SL143435 22,037 81,031
Afu257-E11 80,499 97,008 F13952 78,466 93,926 SL143436 52,604 84,188
Afu343-P11 73,797 101,305 F14403 27,476 74,454 SL143437 61,289 91,394
Afu591-12 80,781 97,039 F14513G 78,647 94,213 SL143438 22,676 81,649
Afu942-09 80,827 97,149 F14532 79,931 102,436 SL143439 39,562 87,955
akuBKU80 1043 78,152 F14946G 44,442 79,719 SL143440 162,993 165,788
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Table 4. Cont.
Samples A1163 Af293 Samples A1163 Af293 Samples A1163 Af293
ATCC 204305 37,614 60,180 F15390 79,743 101,967 SL143441 38,498 72,994
ATCC 46645 84,994 103,941 F15927 161,157 164,076 SL146112 21,782 81,137
CEA10 1009 75,854 F16134 19,660 77,718 TP12 83,363 24,982
CM2141 88,704 107,238 F16216 78,073 90,736 TP32 163,367 162,032
CM237 48,402 83,874 F16311 51,387 78,630 F17582 79,598 97,024
Although the tree topology was maintained regardless of the reference genome chosen,
the number of SNVs within clusters changed significantly when comparing each reference against each
cluster, showing that both reference genomes were genetically very different (Table 3). The number of
SNVs of clusters II and IV were similar against both references, while remarkable differences in SNVs
were present in clusters I (closer to A1163) and III (closer to Af293) (Table 3). Considering subclusters,
the number of SNVs in subclusters I.1, I.2 and I.3 were almost half when the reference genome was the
A1163, than the SNVs obtained using Af293 as reference genome. Another remarkable result was the
small number of SNVs found in cluster III when compared to Af293 genome. The SNV differences
found against both references were slighter but also considerable in cluster II, higher when compared
to A1163. Cluster IV had the greatest number of SNVs, independent of the reference genome used.
Moreover, in order to explore any genomic differences between clusters and subclusters,
some features of the SNVs found in each population were determined (Table 5). This table shows that
all populations had a similar amount of SNVs, excluding cluster IV, which had much more variants,
specifically missense and synonymous, compared to the other clusters.
Table 5. Types of SNVs and features. Variants found within each cluster compared to both genomes.
Variants
A1163 Reference Genome Af293 Reference Genome
I II III IV I II III IV
Frameshift variants 256 512 477 828 446 587 133 819
Inframe deletions 149 278 264 511 246 330 94 527
Inframe insertions 191 369 291 561 325 447 91 556
Intergenic variants 6405 11,107 12,819 6730 13,428 16,394 3,785 8792
Intron variants 1568 3668 3418 9066 3120 4322 960 8670
Missense variants 4342 10,251 10,008 23,107 8766 11,973 2562 22,746
Protein altering 8 19 12 18 16 22 4 21
Start lost 9 16 23 57 21 24 6 57
Stop gained 95 230 264 298 141 218 43 288
Stop lost 13 27 32 61 25 33 9 61
Stop retained 10 22 21 52 17 24 5 52
Synonymous variants 3675 9026 9005 26,080 8189 11,058 2365 25,418
3.5. Genetic Diversity
Evolutionary distances were estimated by computing the mean proportion or number of
nucleotide differences between each subcluster and each reference genome using two different models
provided by MEGA: the p-model and the number of differences model.
The pairwise distance matrices referred to the distance between each genome and the others
in pairs and was calculated and expressed in proportion and number of differences (Tables S2–S5).
The matrices obtained from the mean distance between groups in which each subcluster was compared
to each other, were indicated also as the proportion and number of differences of all these comparisons
(Tables S6 and S7). Cluster IV was identified as the most distant cluster, according to phylogenetic
results, with 123,259, 118,271 and 114,815 differences in SNVs against cluster I, II and III, respectively.
Moreover, while cluster III was more similar to cluster II with 36,031 differences, cluster I was closer
to cluster II than to III with 38,197 and 50,040 differences, respectively. These data were calculated
using Af293 genome as reference. Data using A1163 were not shown since no significant differences
were found.
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Homogeneity within a group or cluster could be inferred through the analysis of the mean
distance within groups (Tables S8 and S9). Cluster IV was the most homogeneous since the number of
differences was lower than in the remaining groups, followed by subcluster II.1, independently of the
genome that was chosen as reference.
3.6. Genome-Wide Visualization of Depth of Coverage
The depth of coverage from a selected group of whole-sequenced genomes was plotted in a Circos
image to make an exploratory analysis, and to visualize similarities and differences in genome structure
(Figure 3). None of the 20 A. fumigatus genomes included in this study displayed chromosomal or
copy number variations. However, small deletions were observed in multiple chromosomes: regions
smaller than 100 kbp seemed to be deleted in chromosomes 3, 4, 5, 6, 7 and 8. Also, what seemed to
be large-scale deletions (bigger than 300 kbp) were detected in the edges of chromosomes 1 and 7 in
genomes of cluster I and II. It is noteworthy that there was a huge red region in chromosome 4 present
in all genomes marked as an expected deletion, even in the two different Af293 genomes downloaded
and sequenced in-house although the reference genome used was the same Af293 strain genome.
Figure 3. Circos representation of whole-genome depth of coverage of 20 A. fumigatus genomes,
averaged over 10,000-bp bins. Red marks showed null coverage, black marks a range of coverage
between 1–500, and green marks showed a coverage higher than 500. Color legend shows the selected
genomes of each cluster: I (blue), II (pink), III (orange) and IV (green).
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3.7. Genome Comparisons Based on Their Mating Type
There were no differences in the strain genetic background between genomes harboring the
mating type 1 or 2. In fact, strain genomes of both mating types were present in all clusters. In order
to detect if there was any differential presence or absence of certain genes based on their particular
mating type, all genomes were divided according to their mating type and mapped to both reference
genomes (Af293, Mat1.2 and A1163, Mat1.1). No differences in the presence of genes were found in
Mat1.1 strain genomes other than those encoded by the Mat1.2 locus itself (Mat1.2.1 and Mat1.2.4).
The same situation was found within strains with Mat1.2 genomes; there were no differences in genes
other than the gene Mat1.1.1 itself encoded by the Mat1.1 locus.
4. Discussion
Different typing techniques have demonstrated remarkable genomic diversity among strains
of A. fumigatus [13,37]. Aspergillus fumigatus is found in multiple environmental niches which
contribute to its genotypic and phenotypic heterogeneity among isolates [38]. Therefore, understanding
the association between genomic diversity and different biological and phenotypic features,
such as the spectrum of pathogenicity and antifungal resistance, among others, is a challenge for
multiple Aspergillus laboratories. In this context, WGS is emerging as a promising tool for strain
characterization [18,39]. Since WGS considers the entire genetic material of every isolate, it provides
the highest discriminatory power that any technique can reach, allowing for the differentiation of
closely related strains [39]. In addition, WGS could emerge as a useful tool for gene detection and other
sequence-based investigations [9]. This source of an unprecedented amount of novel and comparative
data could aid in the development of a huge database which would contain information about the
biological differences between A. fumigatus strains, such as their origin, diversity and population
structure. Previous WGS studies with a suitable depth of coverage had shown variation in genome
structure with small-scale insertions and deletions, and recombination events among A. fumigatus
isolates [40]. However, due to the complexity of biological systems, some difficulties need to be
overcome in order to correlate complex biological traits with genomic features.
To date, most of the WGS studies are based on genome-scale comparisons in which the number of
SNVs of each strain are obtained comparing its genome to a previously selected reference genome.
In this work, we have made all comparison independently using two A. fumigatus reference genomes,
Af293 and A1163. The differential grouping of the A. fumigatus population in four clusters is driven
by the different SNVs found. In fact, the number of SNVs in each cluster and subcluster differed
depending on the reference genome used to determine the number of variants. Particularly, the small
number of SNVs found in cluster III when it was compared to Af293 reference genome is due to the
fact that the genomes included in this cluster were more similar to Af293 and had twice the SNVs
obtained with A1163 as a reference. Because cluster III was the smallest, formed by only five genomes,
the WGS analysis would be improved by the addition of more genomes when available. In addition,
it is important to highlight that the specific five SNVs in cyp51A present in all genomes belonging to
cluster III (F46Y, M172V, N248T, D255E, and E427K) would have not been detected when Af293 genome
was used as reference since those changes are also found in its genome. Other important changes
could have been missed during the analysis depending on which genome was used as a reference,
highlighting the importance of choosing an appropriate reference genome for each case.
The highest number of SNVs was found in cluster IV, which means that was the furthest and most
different population compared to both references (Table 3). In fact, this result was in agreement with
those computed using MEGA. Cluster IV was the most distant (in number of differences as well as
in proportion) from all the subclusters (Tables S6 and S7). When the differences within subclusters
were analyzed (Tables S8 and S9), this cluster had the greatest homogeneity. In conclusion, cluster IV
is the most different A. fumigatus population compared to the others but also the most homogeneously
composed. The results obtained by MEGA to study the evolutionary distances among genomes were
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in line with the results obtained from WGS phylogenetic studies, since the evolutionary distances
supported the formed clusters and subclusters (Figures 1 and 2, Tables S6 and S7).
Regarding the Circos visual representation of the depth of coverage (Figure 3), it is noteworthy
that the described large-scale deletions were detected in the edges of chromosomes 1 and 7, so these
possible deletion events could be confined to telomeric or subtelomeric regions. Notably, all cluster
III genomes did not have these deletions, as well as the reference genome used, which belonged
to this same cluster. Remarkably, a huge deletion in chromosome 4 was present in all genomes.
This might be due to a misassembly or to sequencing errors since two different Af293 genomes
(downloaded and sequenced in-house) were included in the analysis and also had this deletion in
spite of being the same strain that the genome used as reference. Similar results have been found
by other authors although no comments were made about it, probably because it was difficult to
realize without sequencing in-house the Af293 [13]. Areas with higher depth of coverage might be
a consequence of possible duplication events, pseudogene presence or artefacts. However, since these
regions appeared specifically in chromosomes 2, 4 and 6 in most of the genomes of cluster II, it would
be worthy to explore them further. A specific mapping approach should be developed to analyze all
these regions and to determine if there are real duplications and also if they represent a hallmark for
cluster characterization. Further research is in progress to clarify which genes are in these differential
regions and which are their biological processes or functions in which they are involved.
Experimental investigations on A. fumigatus biology and virulence have historically used only
a few particular strains, of which Af293 and A1163 are the most used. More than in any other
comparisons, the genetic background must be highly considered in the genomes used as references,
since it can be responsible for the variability in many biological aspects between isolates and thus
responsible for different phenotypes. The first genome comparison study between Af293 and
A1163 was accomplished in 2007, showing that both genomes were highly syntenic in most regions,
having core genes highly conserved and with levels of identity of 99.8% at the genome level [18].
These results were confirmed later by Fedorova et al. [17]. Specifically, the Af293 genome contained
143 [17] to 208 unique genes [18], while the A1163, 218 [17] to 320 [18]. In both cases, more than
60% of the strain-specific genes were related to cellular metabolism, secondary metabolism, signaling
and transcriptional regulation [17,18]. These sequence divergences could explain the phenotypic
differences described by other authors who reported a high heterogeneity among these two isolates
regarding abiotic stimuli physiological responses, levels of growth, and virulence [15,38,41], as well
as in immunogenic responses [42]. The variability in the total amount of unique genes in each
genome could be due to sequencing errors or, less probably, to new mutations generated during the
repeated subculture [13]. These results are in agreement with our study, in which the Af293 and
the A1163 reference genomes belonged to different phylogenetic clusters which means that there
are considerable differences between both genomes. Therefore, the appropriate election of the most
suitable reference genome in each context will ultimately result in a more appropriate comparison and
lead to solid conclusions.
Apart from the differences already discussed between Af293 and A1163, comparative analyses
of the mating loci showed that both strains belonged to opposite mating types [40,43]. Mating type
genes are not true idiomorphs, as they occupy adjacent positions on the chromosome. Mat1.1 strains
have only one gene in this locus that encodes a transcriptional factor with an alpha box domain
(AFUB_042900, Mat1.1.), while Mat1.2 strains contain a truncated copy of the high mobility group
(HMG) box (Afu3g06170, Mat1.2.1) and another gene (Afu3g06160, Mat1.2.4) needed for heterokaryon
formation as part of the mating process [44–46]. In this study we also checked if there were gene
differences (presence or absence) other than those responsible for the mating type (Mat1.1, Mat1.2.1 and
Mat1.2.4) among both groups of A. fumigatus genomes using an innovative approach (Figure S1).
No gene absences were found in Mat1.1 strain genomes other than those encoded by the Mat1.2 locus
itself (Mat1.2.1 and Mat1.2.4). Some previous works have reported differential gene presence between
Genes 2018, 9, 363 15 of 19
strains that coincidentally had different mating types [17,18]. However, the differences found must be
due to their own different genetic background and not because of their opposite mating type.
One of the main concerns of invasive aspergillosis treatment is the global emergence of azole
resistance. Regarding azole resistance mechanisms, Cyp51A protein is the target of these drugs and
the cyp51A gene is a hotspot for mutations that confer azole resistance. The most common cyp51A
modifications could be grouped into two categories: A. fumigatus strains that harbor cyp51A single
point mutations (G54, G138, M220, or G448) [47–50], and isolates with specific point mutations in
cyp51A gene together with various size tandem repeat (TR) integrations in the promoter of the gene
(TR34/L98H, TR34/L98H/S297T/F495I, TR46/Y121F/T289A, or TR53) [24,51–53]. Moreover, all these
cyp51A modifications have been described to evolve from two different azole resistance acquisition
routes: the first set of strains come from the clinical setting as a consequence of the in-host drug
adaptation after azole exposure in the patient [54], while the second set of isolates with TR insertions
are hypothesized to develop from the azole exposure in the environmental setting [13,37,55–58].
Thanks to the high amount of isolates harboring different azole resistance mechanisms included
in the study, a clear tendency in terms of grouping can be observed. In agreement with previous
studies [13,37,55,56,58–60], all genomes included in our work that harbor a TR integration with single
point mutations in cyp51A gene were grouped in cluster II, while isolates with punctual modifications
in this gene were spread across clusters I and II. The same happened with cyp51A-WT strains that
were distributed across those clusters. Therefore, our study supported the idea that isolates with
punctual modifications in cyp51A (G54, G138, M220, or G448) and also cyp51A-WT strains have
a greater genetic diversity than TR azole resistant isolates (TR34/L98H, TR34/L98H/S297T/F495I),
which reinforces the previously suggested idea that TR resistance mechanisms have developed from
a reduced set of clonally related strains with shorter genetic distances among them [59,60]. In this
study, only genomes from strains which harbor the TR34/L98H resistance mechanism (with or without
the S297T and F495I modifications) have been included. It would be most interesting to include isolates
harboring TR46/Y121F/T289A, and TR53 azole resistance mechanisms. Furthermore, it is noteworthy
that cluster III and IV were formed specifically by particular isolates that harbor 3 or 5 cyp51A
modifications (F46Y, M172V, E427K and F46Y, M172V, N248T, D255E, E427K, respectively). This result
was in agreement with previous studies developed in our group [19]. Further characterization of
clado-specific genes would enhance our understanding of antifungal resistance mechanisms and help
to unravel the environmental route resistance development.
Despite all these known azole resistance mechanisms, there is an increasing number of A. fumigatus
azole resistant isolates for which the underlying mechanism remains unknown [61,62] or which are
independent of cyp51A modifications [63]. The availability of A. fumigatus genomes to compare closely
related strains but with differences in their azole susceptibility phenotype will increase the chance of
finding genetic differences that could explain the phenotypic variations.
In conclusion, a great amount of novel and useful information can be derived from WGS studies.
Here we particularly demonstrated that the selection of strains and reference genomes is crucial
for comparative analysis at genomic and phenotypic level. Further compilation of A. fumigatus data
generated by WGS studies could greatly enhance the understanding of molecular mechanisms involved
in antifungal drug resistance and its development, as well as in many other biological functions that
remain unknown. As the number of A. fumigatus genomes have increasingly been publically available,
researchers will be able to increase the possibilities for data analysis which will ultimately allow them
to come up with possible conclusions about an infinite number of hypotheses.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4425/9/7/363/s1,
Figure S1: Workflow for obtaining genes present in all Mat1.1 samples but not present in Mat1.2 (A); and on
the contrary (B). Table S1: Mapping rate and coverage at 10× of 101 A. fumigatus strains against both reference
genomes. Table S2: MEGA genetic distance estimations: pairwise distance matrix calculating the proportion
of differences (p-model) and using Af293 as reference genome. Table S3: MEGA genetic distance estimations:
pairwise distance matrix calculating the number of differences and using Af293 as reference genome. Table S4:
MEGA genetic distance estimations: pairwise distance matrix calculating the proportion of differences (p-model)
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and using A1163 as reference genome. Table S5: MEGA genetic distance estimations: pairwise distance matrix
calculating the number of differences and using A1163 as reference genome. Table S6: MEGA genetic distance
estimations: mean distances within subclusters calculating the proportion and number of differences and using
Af293 as reference genome. Table S7: MEGA genetic distance estimations: mean distances within subclusters
calculating the proportion and number of differences and using A1163 as reference genome. Table S8: MEGA
genetic distance estimations: matrix of the mean distances between subclusters calculating the proportion and
number of differences and using Af293 as reference genome. Table S9: MEGA genetic distance estimations: matrix
of the mean distances between subclusters calculating the proportion and number of differences and using A1163
as reference genome.
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